Brief: Clinical Laserthermia Systems Says Continues To Maintain Targets For 2026
Feb 20 (Reuters) - Clinical Laserthermia Systems AB CLSRb.ST: Q4 NET SALES SEK 830 THOUSAND Q4 OPERATING LOSS SEK 10,615,000 CONTINUES TO MAINTAIN COMMUNICATED TARGETS FOR 2026 Source text: ID:nWkr7mpvvQ Further company coverage: [CLSRb.ST] (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com;))
Recent news on Clinical Laserthermia Systems AB
See all newsBrief: Clinical Laserthermia Systems AB Resolves On A Directed Issue
Brief: Clinical Laserthermia Appoints Katarina Lundqvist As Permanent CFO
Brief: CLS Announces Outcome In Rights Issue Of Units
Brief: CLS Agrees On Top-Down Guarantee For Rights Issue
Brief: CLS Conducts Rights Issue Of SEK 39.5 Million